Skip to main navigation Skip to search Skip to main content

Use of dolutegravir in combination with rifampicin-based TB therapy in HIV/TB co-infected patients: real-world experience from Leeds, UK

Muge Cevik, Rachel Vincent, Hugh McGann

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Number of pages1
JournalJournal of the international aids society
Volume19
Publication statusPublished - Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this